Pan-coronavirus vaccine
Latest Information Update: 21 Oct 2023
At a glance
- Originator AdaptVac
- Class Subunit vaccines; Viral vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Coronavirus infections
Most Recent Events
- 20 Oct 2023 Preclinical trials in Coronavirus infections (Prevention) in Denmark (Parenteral), before October 2023 (AdaptVac pipeline, October 2023)